Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 22;4(2):ofx078.
doi: 10.1093/ofid/ofx078. eCollection 2017 Spring.

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin

Kristen L Bunnell  1 , Larry H Danziger  1 , Stuart Johnson  2   3
Affiliations

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin

Kristen L Bunnell et al. Open Forum Infect Dis. .

Abstract

Vancomycin is an increasingly important option for the treatment of Clostridium difficile infection, but economic barriers to its use remain significant in the outpatient setting. Generic vancomycin capsules are still inexplicably expensive and not universally covered by insurers. This report highlights the potential adverse consequences of cost-related nonadherence to vancomycin therapy and the challenges that clinicians face when prescribing oral vancomycin.

Keywords: Clostridium difficile; pharmaceutical costs; vancomycin..

PubMed Disclaimer

References

    1. Johnson S, Louie TJ, Gerding DN et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis 2014; 59:345–54. - PubMed
    1. Gallagher JC, Reilly JP, Navalkele B et al. Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection. Antimicrob Agents Chemother 2015; 59:7007–10. - PMC - PubMed
    1. Walker PC, Nagel J. Clostridium difficile relapse secondary to medication access issue AHRQ WebM&M; [serial online]. Available at: https://psnet.ahrq.gov/webmm/case/321/clostridium-difficile-relapse-seco... Published April 2014. Accessed September 25, 2016.
    1. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016; 316:858–71. - PubMed
    1. Alpern JD, Stauffer WM, Kesselheim AS. High-cost generic drugs–implications for patients and policymakers. N Engl J Med 2014; 371:1859–62. - PubMed